Fortfahren mit
Größe auswählen
| Größe/SKU | Verfügbarkeit | Preis |
|---|---|---|
25 μg | Warenkorb auf Verfügbarkeit prüfen | € 663,00 |
Über diesen Artikel
€ 663,00
biological source
human
Quality Segment
recombinant
expressed in E. coli
assay
≥95% (SDS-PAGE)
form
lyophilized powder
potency
0.1000 μg/mL
mol wt
apparent mol wt 8.7 kDa by SDS-PAGE (reducing)
packaging
pkg of 25 μg
storage condition
avoid repeated freeze/thaw cycles (Do not store in a frost-free freezer.)
technique(s)
cell culture | mammalian: suitable
impurities
endotoxin, tested
UniProt accession no.
storage temp.
−20°C
Gene Information
human ... CXCL13(10563)
Biochem/physiol Actions
Physical form
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description ≥95% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, suitable for cell culture | description for serum, plasma, cell culture supernatant and urine | description Prestige Antibodies® Powered by Atlas Antibodies, clone CL10543, purified antibody (Protein A) | description for serum, plasma and cell culture supernatant |
| technique(s) cell culture | mammalian: suitable | technique(s) capture ELISA: suitable | technique(s) immunohistochemistry: 1:200 - 1:500 | technique(s) ELISA: suitable, capture ELISA: suitable |
| assay ≥95% (SDS-PAGE) | assay - | assay - | assay - |
| recombinant expressed in E. coli | recombinant - | recombinant - | recombinant - |
| biological source human | biological source - | biological source mouse | biological source - |
| Quality Level 200 | Quality Level - | Quality Level 100 | Quality Level - |
| form lyophilized powder | form - | form - | form - |
Signalwort
Warning
Gefahrencodes
Hazard Classifications
Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2
Lagerklasse
11 - Combustible Solids
Was ist los?
WGK 2
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Sicherheitshinweise
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.




